A class action lawsuit has been launched in the U.S. District Court for the Eastern District of New York, on behalf of purchasers of the securities from Ekso Bionics Holdings Inc., according to the law firm Brower, Piven.

The securities in question are those ranging from March 15 to Dec. 27, 2017, according to a press release.

Investors interested in becoming a part of the litigation should seek out involvement before March 5 to be added to the list of plaintiffs. Plaintiffs will be sorted until a lead plaintiff, who can speak on behalf of the other plaintiffs, is selected. The lead plaintiff should be one of the applicants who is claiming the greatest loss from Ekso's investment securities in the dates aforementioned.

The complaint stated that the defendants were in violation of the Securities Exchange Act of 1934 by failing to disclose important details such as the Class Period in which there was material weakness in the defendant's internal control.

Ekso clients who have lost more than $100,000 from investment on or after March 15, 2017 who are interested in learning more can apply for plaintiff classification by emailing hoffman@browerpiven.com.